AT2 receptors: Functional relevance in cardiovascular disease
Open accessThe DOI matches its Crossref record; 401 of the 401 references it cites were found in a registry or an index.
Abstract
The renin angiotensin system (RAS) is intricately involved in normal cardiovascular homeostasis. Excessive stimulation by the octapeptide angiotensin II contributes to a range of cardiovascular pathologies and diseases via angiotensin type 1 receptor (AT1R) activation. On the other hand, tElsevier Inc.he angiotensin type 2 receptor (AT2R) is thought to counter-regulate AT1R function. In this review, we describe the enhanced expression and function of AT2R in various cardiovascular disease settings. In addition, we illustrate that the RAS consists of a family of angiotensin peptides that exert cardiovascular effects that are often distinct from those of Ang II. During cardiovascular disease, there is likely to be an increased functional importance of AT2R, stimulated by Ang II, or even shorter angiotensin peptide fragments, to limit AT1R-mediated overactivity and cardiovascular pathologies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–400 of 401
D’Amore, A., Black, M. J., & Thomas, W. G. (2005) · Hypertension · doi:10.1161/01.hyp.0000193504.51489.cf · Cited by 133 · cited 4×
“However, a study in which cultured cardiomyocytes were transfected with AT1R and AT2R failed to detect any influence of AT2R over-expression on AT1R signaling pathways (D'Amore et al., 2005), suggesting that further confirmation”
BackgroundInfluentialCao, Z., Kelly, D. J., Cox, A. J., CASLEY, D. J., Forbes, J. M., Martinello, P., Dean, R. G., Gilbert, R. E., & Cooper, M. E. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00427.x · Cited by 133 · cited 2×
“Generally, AT2R mRNA and protein have been found to be distributed throughout tubular and vascular segments of the renal cortex and medulla, however, the demonstration of glomerular AT2R is more variable (Ozono et al., 1997; Miyata et al., 1999; Cao et al., 2000; Ruiz-Ortega et al., 2003).”
BackgroundMuller, D. N., Klanke, B., Feldt, S., Cordasic, N., Hartner, A., Schmieder, R. E., Luft, F. C., & Hilgers, K. F. (2008) · Hypertension · doi:10.1161/hypertensionaha.107.101493 · Cited by 132 · cited 2×
“…the beneficial effects of HRP in vivo, and thus saw no improvement in end-organ damage following HRP administration in double-transgenic rats overexpressing renin and angiotensinogen genes (Feldt et al., 2008b), or in renovascular hypertensive 2-kidney, 1-clip (2K1C) rats (Muller et al., 2008).”
BackgroundEffect of AT2receptor blockade on the pathogenesis of renal fibrosis
Morrissey, J. J., & Klahr, S. (1999) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1999.276.1.f39 · Cited by 131 · cited 2×
“Thus, on balance, AT 2 R appear to be renoprotective, in keeping with other studies in which mice treated with PD123319, or in mice with AT 2 R deleted, exhibit marked increases in renal fibrosis (Ma et al., 1998; Morrissey & Klahr, 1999) .”
ResultSuzuki, J., Iwai, M., Nakagami, H., Wu, L., Chen, R., Sugaya, T., Hamada, M., Hiwada, K., & Horiuchi, M. (2002) · Circulation · doi:10.1161/01.cir.0000024103.04821.86 · Cited by 130 · cited 2×
“It has also been demonstrated that AT2R knockout mice show decreased apoptosis in the neointima which is consistent with the increased neointimal formation observed following cuff placement (Suzuki et al., 2002).”
BackgroundLokuta, A. J., Cooper, C., Gaa, S. T., Wang, H. E., & Rogers, T. B. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37619-6 · Cited by 129 · cited 2×
“Ang II stimulation of neonatal rat cardiomyocytes (Lokuta et al., 1994) , rabbit proximal tubule epithelia (Jacobs & Douglas, 1996) , and cultured neurons (Zhu et al., 1998) , increased PLA 2 activity and arachadonic acid (AA) release.”
BackgroundCosentino, F., Savoia, C., DEPAOLIS, P., Francia, P., RUSSO, A., Maffei, A., Venturelli, V., Schiavoni, M., Lembo, G., & Volpe, M. (2005) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2004.11.007 · Cited by 128 · cited 25×
“However, in analogous experiments, Duke et al. (2005a) reported that AT2R contributed to the BP-lowering and mesenteric vasodilator effect of candesartan in normotensive, but not hypertensive (SHR, 2K1C) rats.”
BackgroundResultInfluentialAkishita, M., Iwai, M., Wu, L., Zhang, L., Ouchi, Y., Dzau, V. J., & Horiuchi, M. (2000) · Circulation · doi:10.1161/01.cir.102.14.1684 · Cited by 128 · cited 4×
“Nevertheless, the cardiac hypertrophic effects of AT2R are controversial, with either no effect or hypertrophy being attributed to cardiac AT2R in different AT2R knockout strains subjected to various cardiac loads (Akishita et al., 2000b; Senbonmatsu et al., 2000; Widdop et al., 2003).”
BackgroundInfluentialDeletion of Angiotensin II Type 2 Receptor Exaggerated Atherosclerosis in Apolipoprotein E–Null Mice
Iwai, M., Chen, R., Li, Z., Shiuchi, T., Suzuki, J., Ide, A., Tsuda, M., Okumura, M., Min, L., Mogi, M., et al. (2005) · Circulation · doi:10.1161/circulationaha.104.525550 · Cited by 128 · cited 4×
“…the anti-atherosclerotic effect of the AT1R antagonist, valsartan was markedly reduced in AT2R/ApoE-DKO compared with ApoE-single knockout mice (Iwai et al., 2005), suggesting that AT2R contribute to the beneficial effect of AT1R blockade and are counter-regulatory to AT1R in the setting of…”
BackgroundInfluentialAngiotensin II- and IV-induced changes in cerebral blood flow
Kramár, E. A., Harding, J. W., & Wright, J. W. (1997) · Regulatory Peptides · doi:10.1016/s0167-0115(96)02116-7 · Cited by 128 · cited 1×
“However, Ang IV also induced vasodilatation, (Kramar et al., 1997; Patel et al., 1998; Chen et al., 2000) and has been shown to increase eNOS activation and subsequent NO release (Patel et al., 1998; Hill-Kapturczak et al., 1999) which represents a protective effect in the vasculature.”
BackgroundLemos, V. S., Silva, D. M. R., Walther, T., Alenina, N. V., Bäder, M., & Santos, R. A. S. (2005) · Journal of Cardiovascular Pharmacology · doi:10.1097/01.fjc.0000175237.41573.63 · Cited by 128 · cited 2×
“The functional antidiuretic and vasodilator effects of AVE0991 are absent in MasR-deficient mice (Pinheiro et al., 2004; Lemos et al., 2005), although in some instances either MasR blockade (with A-779) or AT2R blockade (with PD123319) can markedly attenuate the effects of AVE0991 (Wiemer et al.,…”
BackgroundCao, Z., Bonnet, F., Candido, R., Nesteroff, S. P., Burns, W. C., Kawachi, H., Shimizu, F., Carey, R. M., de Gasparo, M., & Cooper, M. E. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000019409.17099.33 · Cited by 126
Ferreira, A. J., Jacoby, B. A., Araújo, C. A. A., Macedo, F. A. F. F., Silva, G. A. B., Almeida, A. P., Caliari, M. V., & Santos, R. A. S. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00828.2006 · Cited by 126 · cited 1×
“More recently, chronic AVE0991 administration was reported to attenuate heart failure induced by MI (Ferreira et al., 2007) although the ATR subtype mediating this effect was not investigated.”
BackgroundKijima, K., Matsubara, H., Murasawa, S., Maruyama, K., Mori, Y., Ohkubo, N., Komuro, I., Yazaki, Y., Iwasaka, T., & Inada, M. (1996) · Circulation Research · doi:10.1161/01.res.79.4.887 · Cited by 126 · cited 2×
“In vitro studies have demonstrated increased AT2R expression due to stabilization of mRNA following cardiomyocyte stretch, providing a potential mechanism for observed enhancement of AT2R density during situations of cardiac overload (Kijima et al., 1996).”
BackgroundRenin Inhibition by Aliskiren Prevents Atherosclerosis Progression
Nussberger, J., Aubert, J.-F., Bouzourène, K., Pellegrin, M., Hayoz, D., & Mazzolai, L. (2008) · Hypertension · doi:10.1161/hypertensionaha.108.110932 · Cited by 126 · cited 2×
“Moreover, Nussberger et al.”
Reinecke, K., Lucius, R., Reinecke, A., Rickert, U., Herdegen, T., & Unger, T. (2003) · The FASEB Journal · doi:10.1096/fj.02-1193fje · Cited by 125 · cited 1×
“Reinecke et al. (2003) demonstrated that angiotensin II can act similarly to NGF, promoting remyelination, neurite outgrowth and functional recovery following sciatic nerve crush in adult rats via AT2R (Reinecke et al., 2003).”
BackgroundAngiotensin II-Mediated Development of Vascular Diseases
Daugherty, A. (2004) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2004.01.002 · Cited by 123 · cited 2×
“…the pathogenesis of atherosclerosis (Daugherty et al., 2000), with AT1-receptor activation by Ang II promoting vascular inflammation, cellular proliferation and oxidative stress which are considered key stages in the initiation and progression of the disease (Dzau, 2001; Daugherty & Cassis, 2004).”
BackgroundLopez-Ilasaca, M. A., Liu, X., Tamura, K., & Dzau, V. J. (2003) · Molecular Biology of the Cell · doi:10.1091/mbc.e03-06-0383 · Cited by 123
Boulanger, C. M., Caputo, L., & Levy, B. I. (1995) · Hypertension · doi:10.1161/01.hyp.26.5.752 · Cited by 123 · cited 2×
“, 2003), and N1E-115 neuroblastoma cells, and in isolated blood vessels from animal (Boulanger et al., 1995; Seyedi et al., 1995; Thorup et al., 1998; Thorup et al., 1999; Hannan et al., 2003), and human (Batenburg et al.”
BackgroundAngiotensin-Converting Enzyme Expression in Human Carotid Artery Atherosclerosis
Fukuhara, M., Geary, R. L., Diz, D. I., Gallagher, P. E., Wilson, J. A., Glazier, S. S., Dean, R. H., & Ferrario, C. M. (2000) · Hypertension · doi:10.1161/01.hyp.35.1.353 · Cited by 123 · cited 2×
“The role of Ang II in atherosclerosis is evident in a number of studies using transgenic animal models and human tissues, that demonstrate an increase in AT 1 -receptor density in hypercholesterolemia (Nickenig & Bohm, 1997; Warnholtz et al., 1999) , as well as increased expression of ACE in atherosclerotic lesions (D…”
BackgroundPadia, S. H., Kemp, B. A., Howell, N. L., Fournie-Zaluski, M.-C., Roques, B. P., & Carey, R. M. (2008) · Hypertension · doi:10.1161/hypertensionaha.107.103242 · Cited by 119 · cited 2×
“These binding data fit with the relatively few functional studies that have examined ATR subtype effects of Ang III, since both in vivo (Walters et al., 2003; Padia et al., 2006 Padia et al., , 2007 Padia et al., , 2008 and cellular signaling (Lorenzo et al., 2002) studies have implicated an AT 2 R-selective effect of…”
BackgroundRole of AT1and AT2receptors in regulation of MAPKs and MKP-1 by ANG II in adult cardiac myocytes
Fischer, T. A., Singh, K., O’Hara, D. S., Kaye, D. M., & Kelly, R. A. (1998) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1998.275.3.h906 · Cited by 119 · cited 3×
“Thus Ang II stimulation of AT2R may result in activation of PTPases via both G-proteindependent and -independent mechanisms.”
BackgroundKim, S., Kawamura, M., Wanibuchi, H., Ohta, K., Hamaguchi, A., Omura, T., Yukimura, T., Miura, K., & Iwao, H. (1995) · Circulation · doi:10.1161/01.cir.92.1.88 · Cited by 119 · cited 1×
“The RAS has been implicated in neointimal formation mainly via the activation of the AT1R (Kim et al., 1995; Viswanathan et al., 1992).”
BackgroundEstrogen upregulates renal angiotensin II AT1 and AT2 receptors in the rat
Baiardi, G., Macova, M., Armando, I., Ando, H., Tyurmin, D., & Saavedra, J. M. (2004) · Regulatory Peptides · doi:10.1016/j.regpep.2004.06.021 · Cited by 118 · cited 1×
“Discrepancies between studies may involve species differences since renal AT2R are more easily detected in mice than rats (Armando et al., 2002; Baiardi et al., 2005).”
BackgroundMatrougui, K., Loufrani, L., Heymes, C., Lévy, B. I., & Henrion, D. (1999) · Hypertension · doi:10.1161/01.hyp.34.4.659 · Cited by 118 · cited 2×
“…normotensive animals; interestingly, there is little evidence of AT2R-mediated vasorelaxation in arteries taken from untreated hypertensive animals (Matrougui et al., 1999; Matrougui et al., 2000; Cosentino et al., 2005) which contrasts the afore- mentioned in vivo data (Barber et al., 1999; Li &…”
BackgroundCultured Myofibroblasts Generate Angiotensin Peptidesde Novo
Katwa, L. C., Campbell, S. E., Tyagi, S. C., Lee, S. J., Cicila, G. T., & Weber, K. T. (1997) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1997.0376 · Cited by 116 · cited 1×
“Moreover, important factors involved in Ang II-mediated connective tissue formation, including TGF-β1 and its receptors, and type I and III collagens, are also expressed in AT2R-rich fibroblasts and myofibroblasts (Katwa et al., 1997; Lijnen et al., 2003).”
BackgroundThe Cardiac Renin-Angiotensin System in STZ-Induced Diabetes
Sechi, L. A., Griffin, C. A., & Schambelan, M. (1994) · Diabetes · doi:10.2337/diab.43.10.1180 · Cited by 116 · cited 2×
“Increased expression of AT 2 R in normal (Sechi et al., 1994) and cardiomyopathic (Li et al., 2005a) hearts from diabetic rats have been reported.”
BackgroundPhysiological and Pathophysiological Functions of the AT2Subtype Receptor of Angiotensin II
Henrion, D., Kubis, N., & Levy, B. I. (2001) · Hypertension · doi:10.1161/hy1101.096109 · Cited by 115 · cited 1×
“For further detailed analysis of AT2R-mediated relaxation/vasodilatation, see (Hannan & Widdop, 2004; Henrion et al., 2001; Widdop et al., 2008).”
BackgroundChronic pretreatment with candesartan improves recovery from focal cerebral ischaemia in rats
Groth, W., Blume, A., Gohlke, P., Unger, T., & Čulman, J. (2003) · Journal of Hypertension · doi:10.1097/00004872-200311000-00028 · Cited by 113 · cited 1×
“In accordance with human clinical trials, animal studies have also concluded that inhibition of the RAS protects against neuronal injury following stroke, often in a BP-independent manner (Ito et al., 2002; Groth et al., 2003).”
ResultSavoia, C., Tabet, F., Yao, G., Schiffrin, E. L., & Touyz, R. M. (2005) · Journal of Hypertension · doi:10.1097/01.hjh.0000166845.49850.39 · Cited by 113 · cited 3×
“This potentiated NO signaling decreased RhoA/Rho kinase activation, reduced MLC phosphorylation, and subsequently unmasked AT2R-mediated vasorelaxation to Ang II, providing evidence for mechanisms of AT1/AT2R crosstalk at a signaling level (Savoia et al., 2005).”
BackgroundLocal Angiotensin II Generation in the Rat Heart: Role of Renin Uptake
Müller, D. N., Fischli, W., Clozel, J., Hilgers, K. F., Bohlender, J. M., Ménard, J., Busjahn, A., Ganten, D., & Luft, F. C. (1998) · Circulation Research · doi:10.1161/01.res.82.1.13 · Cited by 111 · cited 2×
“Indeed it was demonstrated that amajor source of renin/prorenin in cardiac tissue is due to sequestration and uptake from the circulation (Danser et al., 1994; Muller et al., 1998) suggesting a functional role for prorenin.”
BackgroundLehtonen, J. Y. A., Horiuchi, M., Daviet, L., Akishita, M., & Dzau, V. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.24.16901 · Cited by 109 · cited 1×
“Long-term stimulation of AT2R by Ang II has also been shown to increase synthesis of ceramides, which may then activate stress kinases and caspases involved in the induction of apoptosis (Gallinat et al., 1999; Lehtonen et al., 1999).”
BackgroundRenin receptor expression in human adipose tissue
Achard, V., Boullu-Ciocca, S., Desbriere, R., Nguyen, G., & Grino, M. (2007) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00439.2005 · Cited by 109 · cited 2×
“heart, brain, placenta and adipocytes, and at lower levels in kidney and liver (Danser & Deinum, 2005; Nguyen, 2006; Achard et al., 2007).”
BackgroundIschemic injury in experimental stroke depends on angiotensin II
Walther, T., Oláh, L., Harms, C., Maul, B., Bäder, M., Hörtnagl, H., Schultheiss, H., & Mies, G. (2002) · The FASEB Journal · doi:10.1096/fj.01-0601com · Cited by 106 · cited 1×
“Similarly, AT1R knock out mice, exhibited smaller infarct size following temporary middle cerebral artery occlusion (Walther et al., 2002).”
BackgroundType 1 angiotensin receptor pharmacology: Signaling beyond G proteins
Oro, C., Qian, H., & Thomas, W. G. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.10.001 · Cited by 106 · cited 2×
“It is well established that GPCRs are susceptible to receptor dimerisation, and that such an interaction between receptors may affect both receptor activation and signaling, as has been well described for AT1R (Oro et al., 2007).”
BackgroundYou, D., Loufrani, L., Baron, C., Levy, B. I., Widdop, R. E., & Henrion, D. (2005) · Circulation · doi:10.1161/01.cir.0000156503.62815.48 · Cited by 105 · cited 10×
“These studies confirmed the upregulation of AT 2 R following anti-hypertensive treatments and identified that AT 2 R were re-expressed at the level of the endothelium (You et al., 2005) .”
BackgroundInfluentialSelf-citationDifferential role of angiotensin II receptor subtypes on endothelial superoxide formation
Sohn, H. Y., Raff, U., Hoffmann, A., Gloe, T., Heermeier, K., Galle, J., & Pohl, U. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703566 · Cited by 105 · cited 2×
“These results suggest inhibitory modulation of oxidative stress via the AT 2 R which is consistent with in vitro data using cultured endothelial cells in which AT 2 R blockade with PD123319 enhanced superoxide formation (Sohn et al., 2000) .”
ResultMogi, M., Li, J., Iwanami, J., Min, L., Tsukuda, K., Iwai, M., & Horiuchi, M. (2006) · Hypertension · doi:10.1161/01.hyp.0000229648.67883.f9 · Cited by 105 · cited 7×
“In this context, the neuroprotective effect of valsartan was reduced in AT2R knockout animals (Iwai et al., 2004; Mogi et al., 2006), and either peripheral (Lu et al., 2005) or central (Li et al., 2005b) administration of an AT2R antagonist reversed the neuroprotection evoked by AT1R blockade,…”
BackgroundInfluentialGilbert, R. E., Krum, H., Wilkinson‐Berka, J. L., & Kelly, D. J. (2003) · Diabetic Medicine · doi:10.1046/j.1464-5491.2003.00979.x · Cited by 105 · cited 2×
“Diabetes is one of the major causes of renal failure and blindness and is an important risk factor for the development of cardiovascular disease, where its presence is also associated with a worse prognosis (Gilbert et al., 2003) .”
BackgroundSavoia, C., Ebrahimian, T., He, Y., Gratton, J., Schiffrin, E. L., & Touyz, R. M. (2006) · Journal of Hypertension · doi:10.1097/01.hjh.0000251902.85675.7e · Cited by 103 · cited 5×
“Interestingly, AT1R blockade was shown to increase AT2R expression (2–3-fold) and NO production, and to suppress NAD(P)H-driven superoxide generation, in arteries of hypertensive SHRSP, but not normotensive WKY rats (Savoia et al., 2006a).”
BackgroundInfluentialAngiotensin II Type 2 Receptor Inhibits Cell Proliferation and Activates Tyrosine Phosphatase
Tsuzuki, S., Matoba, T., Eguchi, S., & Inagami, T. (1996) · Hypertension · doi:10.1161/01.hyp.28.5.916 · Cited by 103 · cited 4×
“Increased PTPase activity following AT 2 R stimulation has been demonstrated in PC12W cells (Bottari et al., 1992; Brechler et al., 1994) , N1E-115 neuroblastoma cells (Nahmias et al., 1995) and R3T3 fibroblasts (Tsuzuki et al., 1996) .”
BackgroundInfluentialWu, L., Iwai, M., Nakagami, H., Chen, R., Suzuki, J., Akishita, M., de Gasparo, M., & Horiuchi, M. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/hq0102.102277 · Cited by 102 · cited 7×
“…fibrosis, as the promotion of interstitial fibrosis by either aortic banding or L-NAMEwas augmented in AT2R knockout mice (Akishita et al., 2000b; Wu et al., 2002; Gross et al., 2004) and cardiac specific over-expression of AT2R diminished the amount of both perivascular and interstitial…”
BackgroundResultInfluentialSchmieder, R. E., Erdmann, J., Delles, C., Jacobi, J., Fleck, E., Hilgers, K. F., & Regitz‐Zagrosek, V. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)01063-9 · Cited by 101 · cited 2×
“In hypertensive subjects, LVH has been associated with either the A allele (Schmieder et al., 2001) or the G allele (Alfakih et al., 2004) in 2 separate studies, with the method of LVH determination (echocardiography versus magnetic resonance imaging) suggested as explanation for these…”
ResultBrassard, P., Amiri, F., & Schiffrin, E. L. (2005) · Hypertension · doi:10.1161/01.hyp.0000176744.15592.7d · Cited by 101 · cited 4×
“Similarly, in Ang II-induced hypertension, simultaneous blockade of AT 1 and AT 2 R by Sar-Ile resulted in greater media:lumen ratio than that due to AT 1 R blockade alone in both aortic and mesenteric vessels, suggesting an AT 2 R-mediated anti-hypertrophic effect (Brassard et al., 2005) .”
BackgroundResultInfluentialAkishita, M., Ito, M., Lehtonen, J. Y. A., Daviet, L., Dzau, V. J., & Horiuchi, M. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5182 · Cited by 100 · cited 1×
“Consequently, it was originally believed that the AT2R was primarily involved in cellular growth and differentiation (Capponi, 1996; Akishita et al., 1999; Yamada et al., 1999).”
BackgroundColeman, J. K. M., Krebs, L. T., Hamilton, T. A., Ong, B., Lawrence, K. A., Sardinia, M. F., Harding, J. W., & Wright, J. W. (1998) · Peptides · doi:10.1016/s0196-9781(97)00291-x · Cited by 98 · cited 2×
“…in effects such as enhancement of cognitive function (Wright et al., 1993; Wright et al., 1999) modulation of blood flow (Swanson et al., 1992; Coleman et al., 1998), increased natriuresis (Ardaillou & Chansel, 1997) and inhibition of cardiomyocyte hypertrophy (Baker & Aceto, 1990; Baker et…”
BackgroundEsteban, V., Rupérez, M., Sánchez‐López, E., Rodríguez‐Vita, J., Lorenzo, Ó., Demaegdt, H., Vanderheyden, P., Egido, J., & Ruiz‐Ortega, M. (2005) · Circulation Research · doi:10.1161/01.res.0000166326.91395.74 · Cited by 97 · cited 1×
“On the other hand, Esteban et al. (2005) recently demonstrated that Ang IV activated NFκB and subsequently increased pro-inflammatory mediator expression in cultured VSMCs, via AT4R and independently of AT1R or AT2R.”
BackgroundZhou, J., Pavel, J., Macova, M., Yu, Z., Imboden, H., Ge, L., Nishioku, T., Dou, J., DelGiacco, E., & Saavedra, J. M. (2006) · Stroke · doi:10.1161/01.str.0000217404.64352.d7 · Cited by 97 · cited 1×
“The fact that a sartan itself leads to an upregulation of AT2R in cerebral vessels (Zhou et al., 2006) is consistent with a vascular component to the neuroprotective effect of AT2R stimulation.”
BackgroundCôté, F., Hung, T., Laflamme, L., Gallo, J., & Gallo‐Payet, N. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.44.31686 · Cited by 97 · cited 2×
“Likewise, it was found that selective activation of AT2R increased the expression of beta III-tubulin, and the microtubule-associated proteins, tau and MAP2, resulting in increased elongation of neuritis (Cote et al., 1999).”
BackgroundRogg, H., de Gasparo, M., Graedel, E., Stulz, P., Burkart, F., Eberhard, M., & Erne, P. (1996) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a015008 · Cited by 95 · cited 1×
“Moreover, a correlation between AT2R density and severity of heart failure has been reported (Rogg et al., 1996), raising the obvious question of whether or not such increased AT2R expression represents a causative or a reactive consequence of LVH.”
BackgroundTea, B.-S., Der Sarkissian, S., Touyz, R. M., Hamet, P., & deBlois, D. (2000) · Hypertension · doi:10.1161/01.hyp.35.5.1069 · Cited by 95 · cited 6×
“Importantly, this AT2R-mediated vascular anti-hypertrophic effect was not simply a consequence of sartan-induced BP-lowering, as simultaneous PD123319 administration had no further influence on BP in these studies (Tea et al., 2000; Jones et al., 2004).”
BackgroundMethodResultInfluentialExpression of angiotensin II AT2 receptor mRNA during development of rat kidney and adrenal gland
Shanmugam, S., Llorens‐Cortés, C., Clauser, É., Corvol, P. L., & Gasc, J. (1995) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1995.268.5.f922 · Cited by 95 · cited 2×
“AT 2 R are also developmentally regulated in the kidney, with AT 2 R expression higher than that of AT 1 R expression in the foetal kidney (Ciuffo et al., 1993; Shanmugam et al., 1995; Ozono et al., 1997) .”
BackgroundIn Vivo Study of AT1and AT2Angiotensin Receptors in Apoptosis in Rat Blood Vessels
Diep, Q. N., Li, J., & Schiffrin, E. L. (1999) · Hypertension · doi:10.1161/01.hyp.34.4.617 · Cited by 95 · cited 1×
“…acute Ang II infusion decreased BP. Stimulation of AT2R by chronic Ang II infusion during AT1R blockade failed to decrease BP (Cao et al., 1999; Diep et al., 1999), and similarly, chronic AT2R inhibition either had no (Liu et al., 1997; Tea et al., 2000) or minimal (Varagic et al., 2001)…”
BackgroundConversion of brain angiotensin II to angiotensin III is critical for pressor response in rats
Wright, J. W., Tamura-Myers, E., Wilson, W. L., Roques, B. P., Llorens‐Cortés, C., Speth, R. C., & Harding, J. W. (2003) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00326.2002 · Cited by 95 · cited 2×
“This lack of potency of Ang III is not usually the case in the central nervous system where it is proposed that Ang III is the main mediator of centrally-mediated pressor effects of Ang II, following conversion from the latter (Reaux et al., 2001; Wright et al., 2003) .”
BackgroundRegulation of angiotensin II type 1 (AT1) receptor function
Thomas, W. G. (1999) · Regulatory Peptides · doi:10.1016/s0167-0115(98)00140-2 · Cited by 95 · cited 1×
“By contrast, AT1R were rapidly internalized (Hein et al., 1997; Thomas,1999), which is consistent with functional data (Widdop et al., 2002).”
ResultStroth, U., Meffert, S. H., Gallinat, S., & Unger, T. (1998) · Molecular Brain Research · doi:10.1016/s0169-328x(97)00298-2 · Cited by 94 · cited 3×
“Stroth et al. (1998) identified that the AT2R is involved in the regulation of cytoskeleton proteins essential for neurite extension (Stroth et al., 1998).”
BackgroundInfluentialBatenburg, W. W., de Bruin, R. J. A., van Gool, J. M. G., Müller, D. N., Bader, M., Nguyen, G., & Danser, A. H. J. (2008) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.164210 · Cited by 94 · cited 11×
“Over-expression of AT2R in cultured fibroblasts, CHO cells and VSMCs, caused apoptosis via p38 MAPK and caspase-3 signalling pathways (Miura & Karnik, 2000).”
BackgroundInfluentialTouyz, R. M., He, G., Mabrouk, M. E., & Schiffrin, E. L. (2001) · Hypertension · doi:10.1161/01.hyp.37.2.574 · Cited by 94 · cited 15×
“Regulation of collagen synthesis also appears to be altered in hypertension, since AT1R-mediated Ang II stimulation of collagen production was potentiated in SHR and occurred via both p38 and ERK1/2 signalling pathways, whereas collagen production was reduced, and dependent on only ERK1/2 activation in WKY (Touyz et a…”
BackgroundInfluentialCardiac Senescence Is Associated with Enhanced Expression of Angiotensin II Receptor Subtypes1
Heymes, C., Silvestre, J.-S., Llorens-Cortes, C., Marotte, F., Chevalier, B., Levy, B. I., Swynghedauw, B., & Samuel, J.-L. (1998) · Endocrinology · doi:10.1210/endo.139.5.6023 · Cited by 93
Hannan, R. E., Davis, E. A., & Widdop, R. E. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705484 · Cited by 92 · cited 2×
“…cells, and in isolated blood vessels from animal (Boulanger et al., 1995; Seyedi et al., 1995; Thorup et al., 1998; Thorup et al., 1999; Hannan et al., 2003), and human (Batenburg et al., 2004) studies, Ang II has been shown to increase NO and/or cGMP levels via AT2R and/ or AT1R…”
BackgroundSelf-citationRole of AT 2 Receptors in the Cardioprotective Effect of AT 1 Antagonists in Mice
Xu, J., Carretero, O. A., Liu, Y.-H., Shesely, E. G., Yang, F., Kapke, A., & Yang, X.-P. (2002) · Hypertension · doi:10.1161/01.hyp.0000029095.23198.ad · Cited by 92 · cited 7×
“In addition, AT2R stimulation has been shown to be involved in the beneficial effects of sartans post-MI, as AT1R inhibition was found to be less effective during AT2R blockade (Liu et al., 1997) or AT2R-deletion (Xu et al., 2002), and potentiated by AT2R-over-expression (Voros et al., 2006).”
BackgroundInfluentialRole of angiotensin AT1 and AT2 receptors in cardiac hypertrophy and cardiac remodelling
Zhu, Y., Zhu, Y.-Z., Lu, N., Wang, M., Wang, Y., & Yao, T. (2003) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2003.03942.x · Cited by 92 · cited 2×
“When the relative proportions of cell types within the heart remain unchanged, hypertrophy is termed adaptive or physiological, however, by far the most prevalent form of cardiac hypertrophy involves disproportionate changes within the cardiac tissue, which ultimately decrease cardiac function, and results in LVH and…”
BackgroundYayama, K., Hiyoshi, H., Imazu, D., & Okamoto, H. (2006) · Hypertension · doi:10.1161/01.hyp.0000244108.30909.27 · Cited by 91 · cited 2×
“AT 2 R-mediated vasorelaxation has also been indirectly implicated in conduit vessels such as the aorta since aortic banding markedly increased aortic AT 2 R expression as well as activating the eNOS/cGMP axis Yayama et al., 2004 Yayama et al., , 2006 .”
BackgroundAT 2 Receptor and Vascular Smooth Muscle Cell Differentiation in Vascular Development
Yamada, H., Akishita, M., Ito, M., Tamura, K., Daviet, L., Lehtonen, J. Y. A., Dzau, V. J., & Horiuchi, M. (1999) · Hypertension · doi:10.1161/01.hyp.33.6.1414 · Cited by 91 · cited 1×
“Consequently, it was originally believed that the AT2R was primarily involved in cellular growth and differentiation (Capponi, 1996; Akishita et al., 1999; Yamada et al., 1999).”
BackgroundBusche, S., Gallinat, S., Bohle, R.-M., Reinecke, A., Seebeck, J., Franke, F. E., Fink, L., Zhu, M., Sumners, C., & Unger, T. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64571-3 · Cited by 90 · cited 1×
“In animal models, AT2R expression is also increased by cardiac hypertrophy and heart failure, either in terms of absolute numbers, or relative to AT1R expression (Suzuki et al., 1993; Lopez et al., 1994; Nio et al., 1995; Ohkubo et al., 1997; Bartunek et al., 1999; Busche et al., 2000).”
BackgroundCardioprotective Role of AT2 Receptor in Postinfarction Left Ventricular Remodeling
Oishi, Y., Ozono, R., Yano, Y., Teranishi, Y., Akishita, M., Horiuchi, M., Oshima, T., & Kambe, M. (2003) · Hypertension · doi:10.1161/01.hyp.0000048340.53100.43 · Cited by 89 · cited 4×
“The vast majority of investigators have deduced AT2Rmediated improvement of LV function and remodelling frommultiple studies performed in mouse models of either AT2R-deletion (Brede et al., 2003; Oishi et al., 2003) or over-expression (Yang et al., 2002; Bove et al., 2005).”
BackgroundInfluentialIchihara, S., Senbonmatsu, T., Price, E., Ichiki, T., Gaffney, F. A., & Inagami, T. (2002) · Circulation · doi:10.1161/01.cir.0000033826.52681.37 · Cited by 89 · cited 8×
“In fact, only 1 study has deduced a negative role for AT 2 R stimulation in this context (Ichihara et al., 2002) , and these discordant results may be due to the alternative strain of knockout mouse used by Ichihara et al., as has been previously discussed (see Widdop et al., 2003) .”
BackgroundResultInfluentialShenoy, U. V., Richards, E. M., Huang, X.-C., & Sumners, C. (1999) · Endocrinology · doi:10.1210/endo.140.1.6396 · Cited by 89
Patel, J. M., Martens, J. R., Li, Y. D., Gelband, C. H., Raizada, M. K., & Block, E. R. (1998) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.1998.275.6.l1061 · Cited by 88 · cited 2×
“However, Ang IV also induced vasodilatation, (Kramar et al., 1997; Patel et al., 1998; Chen et al., 2000) and has been shown to increase eNOS activation and subsequent NO release (Patel et al., 1998; Hill-Kapturczak et al., 1999) which represents a protective effect in the vasculature.”
BackgroundJONES, E., Black, M. J., & Widdop, R. E. (2004) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2004.08.004 · Cited by 87 · cited 18×
“We and others have deduced no influence of AT 2 Rs on cardiac hypertrophy from 'PD-reversal' studies, in which simultaneous PD123319 administration did not modify the cardiac anti-hypertrophic effect of AT 1 R blockade in either aged WKY (Jones et al., 2004) or SHR (Varagic et al., 2001) rats.”
BackgroundResultInfluentialSelf-citationMiura, S.-I., Karnik, S. S., & Saku, K. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500639200 · Cited by 87 · cited 3×
“Interestingly, apoptosis was unaffected by treatment with either Ang II or PD123319, but was prevented by inhibition of disulfide bonding by dithiothreitol, suggesting that not only was AT2R-mediated apoptosis ligandindependent, but that homodimerisation of the AT2R was essential to the observed effect (Miura et al.,…”
BackgroundInfluentialMifune, M., Sasamura, H., Shimizu‐Hirota, R., Miyazaki, H., & Saruta, T. (2000) · Hypertension · doi:10.1161/01.hyp.36.5.845 · Cited by 87 · cited 1×
“In addition, Mifune et al. (2000) also reported that AT2R stimulation by CGP42112 induced collagen synthesis in VSMCs and mesangial cells, but that CGP42112 treatment had the opposite effect in cultured fibroblasts, indicating heterogeneous AT2R-mediated responses in different cell types.”
BackgroundRizkalla, B., Forbes, J. M., Cooper, M. E., & Cao, Z. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000099374.58607.c9 · Cited by 87 · cited 1×
“A link between AT2R and VEGF expression, albeit in a non-diabetic context has also been made (Rizkalla et al., 2003; Sarlos et al., 2003).”
BackgroundLocalization of the ANG II type 2 receptor in the microcirculation of skeletal muscle
Nora, E. H., Munzenmaier, D. H., Hansen-Smith, F. M., Lombard, J. H., & Greene, A. S. (1998) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1998.275.4.h1395 · Cited by 86 · cited 2×
“…retina, skin, and both endothelial and vascular smooth muscle cells (VSMCs) of the vasculature (Viswanathan & Saavedra, 1992; Leung et al., 1997; Nora et al., 1998; Allen et al., 1999;Wang et al., 1999; Wheeler-Schilling et al., 1999; Roulston et al., 2003), and importantly, expression is also…”
BackgroundRenal expression of angiotensin type 2 (AT2) receptors during kidney damage
Ruiz‐Ortega, M., Esteban, V., Suzuki, Y., Rupérez, M., Mezzano, S. A., Ardiles, L. G., Justo, P., Ortíz, A., & Egido, J. (2003) · Kidney International · doi:10.1046/j.1523-1755.64.s86.5.x · Cited by 86 · cited 4×
“…of overt renal damage, such as induced by renal ablation, subtotal nephrectomy, or kidney damage caused by protein overload, AT2R were invariably upregulated (Bautista et al., 2001; Cao et al., 2002; Ruiz-Ortega et al., 2003; Hashimoto et al., 2004; Tejera et al., 2004; Vazquez et al., 2005).”
BackgroundInfluentialGuo, D., Chénier, I., Tardif, V., Orlov, S. N., & Inagami, T. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.09.154 · Cited by 84 · cited 3×
“Conversely, ATRAP has been found to be co-localised with AT1R in renal tubules (Tsurumi et al., 2006), and in vitro studies have demonstrated that over-expression of this protein decreases AT1R-mediated signaling and cellular proliferation, thus suggesting that ATRAP may act as a negative regulator of AT1R signaling (…”
BackgroundZhang, X., Lassila, M., Cooper, M. E., & Cao, Z. (2004) · Hypertension · doi:10.1161/01.hyp.0000113628.94574.0f · Cited by 84 · cited 2×
“Zhang et al.”
BackgroundMechanisms of the Anti-Ischemic Effect of Angiotensin II AT1 Receptor Antagonists in the Brain
Saavedra, J. M., Benický, J., & Zhou, J. (2006) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-006-9009-0 · Cited by 83 · cited 2×
“Thus, the neuroprotective role of the AT2R appears to be complex, and is likely to involve a delicate interplay with AT1R on apoptotic, neuronal regenerative and vascular components in the central nervous system (Saavedra et al., 2006).”
BackgroundLong-term blood pressure telemetry in AT2 receptor-disrupted mice
Gross, V., Milia, A. F., Plehm, R., Inagami, T., & Luft, F. C. (2000) · Journal of Hypertension · doi:10.1097/00004872-200018070-00018 · Cited by 83 · cited 2×
“In AT2R knockout mice (Hein et al., 1995; Ichiki et al., 1995; Gross et al., 2000a), and rats administered AT2R antisense to ‘knockdown’ receptor expression (Wang et al., 2004), both an increase in basal BP and/ or potentiation of the pressor response to exogenous Ang II have been attributed to the…”
BackgroundTubular and Interstitial Cell Apoptosis in the Streptozotocin-Diabetic Rat Kidney
Kumar, D., Zimpelmann, J., Robertson, S., & Burns, K. D. (2004) · Nephron Experimental Nephrology · doi:10.1159/000076749 · Cited by 83 · cited 2×
“It should also be noted that there was increased apoptosis involving tubular and interstitial cells of the cortex and medulla of the kidney in STZ-treated rats (Kumar et al., 2004) .”
BackgroundAT2 receptor‐mediated vasodilatation is unmasked by AT1 receptor blockade in conscious SHR
Li, X. C., & Widdop, R. E. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705838 · Cited by 82 · cited 1×
“Moreover, important factors involved in Ang II-mediated connective tissue formation, including TGF-β1 and its receptors, and type I and III collagens, are also expressed in AT2R-rich fibroblasts and myofibroblasts (Katwa et al., 1997; Lijnen et al., 2003).”
BackgroundSelf-citationEarly streptozotocin-diabetes mellitus downregulates rat kidney AT2receptors
Wehbi, G. J., Zimpelmann, J., Carey, R. M., Levine, D. Z., & Burns, K. D. (2001) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.2001.280.2.f254 · Cited by 82 · cited 4×
“Using the STZ-model of type 1 diabetes, both reductions (Kalinyak et al., 1993; Cheng et al., 1994; Brown et al., 1997; Bonnet et al., 2002) and increases (Brown et al., 1997; Wehbi et al., 2001) in AT1R have been reported.”
BackgroundMethodInfluentialHakam, A. C., & Hussain, T. (2005) · Hypertension · doi:10.1161/01.hyp.0000151622.47814.6f · Cited by 82 · cited 12×
“Moreover, PD123319 reversed the natriuretic and diuretic effects of candesartan, suggesting an involvement of AT2R in the effect of the latter compound (Hakam & Hussain, 2005), consistent with earlier studies (Siragy & Carey, 1999; Siragy et al., 1999).”
BackgroundMethodResultInfluentialBrede, M., Roell, W., Ritter, O., Wiesmann, F., Jahns, R., Haase, A., Fleischmann, B. K., & Hein, L. (2003) · Hypertension · doi:10.1161/01.hyp.0000100445.80029.8e · Cited by 82 · cited 5×
“In addition, AT2R stimulation has been shown to be involved in the beneficial effects of sartans post-MI, as AT1R inhibition was found to be less effective during AT2R blockade (Liu et al., 1997) or AT2R-deletion (Xu et al., 2002), and potentiated by AT2R-over-expression (Voros et al., 2006).”
BackgroundInfluentialMyofibroblasts and local angiotensin II in rat cardiac tissue repair
Weber, K. T., Sun, Y., & Katwa, L. C. (1997) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(96)00116-1 · Cited by 81 · cited 1×
“Importantly, in both physiological (e.g. heart valve leaflets) and pathophysiological (e.g. MI) sites of repair, AT2R are expressed at high levels, along with other RAS components such as angiotensinogen, ACE, and AT1R (Weber et al., 1997).”
BackgroundYan, X., Price, R. L., Nakayama, M., Ito, K. I., Schuldt, A. J. T., Manning, W. J., Sanbe, A., Borg, T. K., Robbins, J. M., & Lorell, B. H. (2003) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00361.2003 · Cited by 81 · cited 6×
“In direct contrast, several in vivo studies have suggested a growthstimulatory role of AT 2 R. Mice in which AT 2 R were over-expressed using the ventricular-specific myosin light-chain promoter, exhibited dilated cardiomyopathy which was associated with increases in both myocyte cross sectional area and fibrosis (Yan…”
BackgroundInfluentialEmerging Concepts of Regulation of Angiotensin II Receptors
Mogi, M., Iwai, M., & Horiuchi, M. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.144154 · Cited by 80 · cited 1×
“This field has recently been reviewed (Mogi et al., 2007).”
Vongpatanasin, W., Thomas, G. D., Schwartz, R., Cassis, L. A., Osborne-Lawrence, S., Hahner, L., Gibson, L. L., Black, S., Samols, D., & Shaul, P. W. (2007) · Circulation · doi:10.1161/circulationaha.106.664854 · Cited by 79 · cited 2×
“Conversely, it was recently reported that C-reactive protein caused systolic hypertension that was directly related to downregulation of vascular AT2R (Vongpatanasin et al., 2007).”
BackgroundPadia, S. H., Kemp, B. A., Howell, N. L., Siragy, H. M., Fournie-Zaluski, M.-C., Roques, B. P., & Carey, R. M. (2007) · Hypertension · doi:10.1161/01.hyp.0000254833.85106.4d · Cited by 79 · cited 4×
“Similarly, Padia et al.showed that Ang III evoked natriuretic effects in conscious rats via AT 2 R stimulation, and that inhibition of aminopeptidase N (and thus prevention of the conversion of Ang III to Ang IV), potentiated sodium excretion (Padia et al., 2006 (Padia et al., , 2007 .”
BackgroundInfluentialHiyoshi, H., Yayama, K., Takano, M., & Okamoto, H. (2005) · Hypertension · doi:10.1161/01.hyp.0000164571.77710.19 · Cited by 79 · cited 1×
“Pressure overload induced by aortic banding in rats (Yayama et al., 2004) and mice (Hiyoshi et al., 2004), or 2K1C hypertension (Hiyoshi et al., 2005), has been shown to upregulate vascular AT2R expression and thus attenuate the AT1R-mediated contractile response to Ang II.”
BackgroundLocalization of angiotensin AT1 and AT2 receptors.
Allen, A. M., Zhuo, J. L., & Mendelsohn, F. A. O. (1999) · PubMed · Cited by 78
Angiotensin II Activates Endothelial Constitutive Nitric Oxide Synthase via AT1 Receptors.
Saito, S., Hirata, Y., Emori, T., Imai, T., & Marumo, F. (1996) · Hypertension Research · doi:10.1291/hypres.19.201 · Cited by 76 · cited 2×
“In cultured endothelial (Chaki & Inagami, 1993; Caputo et al., 1995; Saito et al., 1996; Pueyo et al., 1998), PC12W (Zhao et al., 2003), and N1E-115 neuroblastoma cells, and in isolated blood vessels from animal (Boulanger et al., 1995; Seyedi et al., 1995; Thorup et al., 1998; Thorup et al., 1999;…”
BackgroundChronic angiotensin IV treatment reverses endothelial dysfunction in ApoE-deficient mice
Vinh, A., Widdop, R. E., Drummond, G. R., & Gaspari, T. A. (2007) · Cardiovascular Research · doi:10.1093/cvr/cvm021 · Cited by 76 · cited 5×
“Increased AT2R expression in atherosclerotic plaques in the same ApoE-deficient mouse model was recently confirmed (Johansson et al., 2005; Vinh et al., 2008b), and increased AT2R and ACE2 immunoreactivity was found in atherosclerotic plaques in rabbits, often co-localised withmacrophages (Zulli et…”
BackgroundResultInfluentialSelf-citationSales, V. L., Sukhova, G. K., Lopez-Ilasaca, M. A., Libby, P., Dzau, V. J., & Pratt, R. E. (2005) · Circulation · doi:10.1161/circulationaha.105.541714 · Cited by 75 · cited 3×
“The authors noted a temporal association of AT2R expression and reduced smooth muscle cell content during lesion development, emphasizing an anti-inflammatory and antiproliferative role for AT2R (Sales et al., 2005).”
BackgroundRole of Angiotensin Receptor Subtypes in Mesenteric Vascular Proliferation and Hypertrophy
Cao, Z., Dean, R. G., Wu, L. L., CASLEY, D. J., & Cooper, M. E. (1999) · Hypertension · doi:10.1161/01.hyp.34.3.408 · Cited by 75 · cited 2×
“Stimulation of AT 2 R by chronic Ang II infusion during AT 1 R blockade failed to decrease BP (Cao et al., 1999; Diep et al., 1999) , and similarly, chronic AT 2 R inhibition either had no (Liu et al., 1997; Tea et al., 2000) or minimal (Varagic et al., 2001 ) influence on the anti-hypertensive effect of chronic AT 1…”
BackgroundSouza, A. M. D., Lopes, A. G., Pizzino, C. P., Fossari, R. N., Miguel, N. C. O., Cardozo, F. P., Abi-Abib, R. D. C., Fernandes, M. S., Santos, D. P. A., & Caruso‐Neves, C. (2004) · Regulatory Peptides · doi:10.1016/j.regpep.2004.03.005 · Cited by 74 · cited 1×
“…are other functional andmolecular data to support this claim that Ang (1–7) can stimulate AT2R (Jaiswal et al., 1993; Muthalif et al., 1998; Hansen et al., 2000; Heitsch et al., 2001; De Souza et al., 2004; Castro et al., 2005; Lara Lda et al., 2006) often despite low potency (Hansen et al., 2000).”
BackgroundJaiswal, N., Tallant, E. A., Jaiswal, R. K., Diz, D. I., & Ferrario, C. M. (1993) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38196-6 · Cited by 74 · cited 2×
“Moreover there are other functional andmolecular data to support this claim that Ang (1–7) can stimulate AT2R (Jaiswal et al., 1993; Muthalif et al., 1998; Hansen et al., 2000; Heitsch et al., 2001; De Souza et al., 2004; Castro et al., 2005; Lara Lda et al., 2006) often despite low potency (Hansen et al.”
BackgroundHeymes, C., Bernard Swynghedauw, A., & Chevalier, B. (1994) · Circulation · doi:10.1161/01.cir.90.3.1328 · Cited by 73 · cited 1×
“Circulating levels of Ang II are reduced by aging whereas angiotensinogen, ACE, and AT 1 R are upregulated in both the heart and vasculature (Heymes et al., 1994 (Heymes et al., , 1998 Wang et al., 2003) .”
BackgroundTemporal renal expression of angiogenic growth factors and their receptors in experimental diabetes
Rizkalla, B., Forbes, J. M., Cao, Z., et al. (2005) · Journal of Hypertension · doi:10.1097/00004872-200501000-00026 · Cited by 73 · cited 4×
“Chronic AT1R or AT2R blockade attenuated expression of cytokines and their receptors (Rizkalla et al., 2005).”
BackgroundInfluentialAngiotensin-(1–7) binding at angiotensin II receptors in the rat brain
Rowe, B. P., Saylor, D. L., Speth, R. C., & Absher, D. R. (1995) · Regulatory Peptides · doi:10.1016/0167-0115(95)00010-9 · Cited by 72 · cited 4×
“, 1998), and a low affinity for AT1R (Rowe et al., 1995; Santos et al., 2003) and yet many of its reported physiological effects”
BackgroundInfluentialZhu, M., Gelband, C. H., Moore, J. M., Posner, P., & Sumners, C. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-02-00679.1998 · Cited by 72 · cited 2×
“cultured neurons (Zhu et al., 1998), increased PLA2 activity and arachadonic acid (AA) release.”
BackgroundLara, L. S., Cavalcante, F., Axelband, F., Souza, A. M. D., Lopes, A. G., & Caruso‐Neves, C. (2006) · Biochemical Journal · doi:10.1042/bj20051455 · Cited by 72 · cited 3×
“Moreover there are other functional andmolecular data to support this claim that Ang (1–7) can stimulate AT2R (Jaiswal et al., 1993; Muthalif et al., 1998; Hansen et al., 2000; Heitsch et al., 2001; De Souza et al., 2004; Castro et al., 2005; Lara Lda et al., 2006) often despite low potency (Hansen et al., 2000).”
BackgroundIncrease of angiotensin converting enzyme gene expression in the hypertensive aorta.
Shiota, N., Miyazaki, M., & Okunishi, H. (1992) · Hypertension · doi:10.1161/01.hyp.20.2.168 · Cited by 72 · cited 2×
“Vascular remodelling associated with hypertension occurs at all levels of the vascular tree, and increased local expression of RAS components and subsequent enhanced local Ang II production (Shiota et al., 1992; Jandeleit-Dahm et al., 1997; Wang et al., 2003) , implies an important role of the RAS in this process.”
BackgroundGuo, P., Nishiyama, A., Rahman, M., Nagai, Y., Noma, T., Namba, T., Ishizawa, M., Murakami, K., Miyatake, A., Kimura, S., et al. (2006) · Journal of Hypertension · doi:10.1097/01.hjh.0000226200.73065.5d · Cited by 71 · cited 1×
“Renal-specific over-expression of ARAP1 in mice resulted in hypertension, decreased urine output, and renal hypertrophy (Guo et al., 2006), and as these effects were abrogated by AT1R inhibition, indicate a functional role for ARAP1 in potentiation of AT1R signaling.”
BackgroundSalomone, L. J., Howell, N. L., McGrath, H. E., Kemp, B. A., Keller, S. R., Gildea, J. J., Felder, R. A., & Carey, R. M. (2007) · Hypertension · doi:10.1161/01.hyp.0000251881.89610.ee · Cited by 70 · cited 2×
“Moreover, stimulation of dopamine D 1 -like receptors with fenoldopam caused natriuresis due to recruitment and activation of AT 2 R in renal proximal tubules (Salomone et al., 2007) .”
BackgroundAT2 receptor stimulation induces generation of ceramides in PC12W cells
Gallinat, S., Busche, S., Schütze, S., Krönke, M., & Unger, T. (1999) · FEBS Letters · doi:10.1016/s0014-5793(98)01675-5 · Cited by 70 · cited 1×
“Long-term stimulation of AT2R by Ang II has also been shown to increase synthesis of ceramides, which may then activate stress kinases and caspases involved in the induction of apoptosis (Gallinat et al., 1999; Lehtonen et al., 1999).”
BackgroundLee, J., Mustafa, T., McDowall, S. G., Mendelsohn, F. A. O., Brennan, M. E., Lew, R. A., Albiston, A. L., & Chai, S. Y. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.045492 · Cited by 70 · cited 2×
“In addition, Leu-Val-Val-hemorphin-7 (LVV-hemorphin-7), which was first identified as a ligand based on its ability to displace 125I-Ang IV (Lee et al., 2003) also mimics the biological effects of Ang IV such as enhanced memory and learning retention.”
BackgroundFunctional Reconstitution of the Angiotensin II Type 2 Receptor and GiActivation
Hansen, J. L., Servant, G., Baranski, T., Fujita, T., Iiri, T., & Sheikh, S. P. (2000) · Circulation Research · doi:10.1161/01.res.87.9.753 · Cited by 69 · cited 8×
“This hexapeptide has a much lower binding affinity than Ang II for AT2R (Bouley et al., 1998; Hansen et al., 2000), unlike AT4R; nevertheless there are functional data indicating that Ang IV exerts vascular effects via AT2R (Loufrani et al., 1999; Faure et al., 2006).”
BackgroundInfluentialAngiotensin receptor blockers and cerebral protection in stroke
Thöne‐Reineke, C., Steckelings, U. M., & Unger, T. (2006) · Journal of Hypertension · doi:10.1097/01.hjh.0000220416.07235.37 · Cited by 69 · cited 1×
“These authors indicated that AT2R was upregulated during stroke and supported neuronal survival and neurite outgrowth in vulnerable peri-ischemic brain areas, as has recently been reviewed (Thone-Reineke et al., 2006).”
BackgroundUp-Regulation of Angiotensin II Type 2 Receptor in Rat Thoracic Aorta by Pressure-Overload
Yayama, K., Horii, M., Hiyoshi, H., Takano, M., Okamoto, H., Kagota, S., & Kunitomo, M. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.058420 · Cited by 68 · cited 3×
“Pressure overload induced by aortic banding in rats (Yayama et al., 2004) and mice (Hiyoshi et al., 2004), or 2K1C hypertension (Hiyoshi et al., 2005), has been shown to upregulate vascular AT2R expression and thus attenuate the AT1R-mediated contractile response to Ang II.”
BackgroundJacobs, L., & Douglas, J. G. (1996) · Hypertension · doi:10.1161/01.hyp.28.4.663 · Cited by 67 · cited 2×
“Ang II stimulation of neonatal rat cardiomyocytes (Lokuta et al., 1994) , rabbit proximal tubule epithelia (Jacobs & Douglas, 1996) , and cultured neurons (Zhu et al., 1998) , increased PLA 2 activity and arachadonic acid (AA) release.”
BackgroundAngiotensin-II stimulates nitric oxide release in isolated perfused renal resistance arteries
Thorup, C., Kornfeld, M., Winaver, J. M., Goligorsky, M. S., & Moore, L. C. (1998) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s004240050535 · Cited by 67 · cited 2×
“…PC12W (Zhao et al., 2003), and N1E-115 neuroblastoma cells, and in isolated blood vessels from animal (Boulanger et al., 1995; Seyedi et al., 1995; Thorup et al., 1998; Thorup et al., 1999; Hannan et al., 2003), and human (Batenburg et al., 2004) studies, Ang II has been shown to increase NO…”
BackgroundLocalization of angiotensin II receptor subtypes AT1 and AT2 in the pancreas of rodents
Leung, P. S., Chan, H. C., Fu, L. X. M., & Wong, P. Y. D. (1997) · Journal of Endocrinology · doi:10.1677/joe.0.1530269 · Cited by 65 · cited 2×
“…uterus, pancreas, retina, skin, and both endothelial and vascular smooth muscle cells (VSMCs) of the vasculature (Viswanathan & Saavedra, 1992; Leung et al., 1997; Nora et al., 1998; Allen et al., 1999;Wang et al., 1999; Wheeler-Schilling et al., 1999; Roulston et al., 2003), and importantly,…”
BackgroundWheeler‐Schilling, T. H., Köhler, K., Sautter, M., & Guenther, E. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00787.x · Cited by 63 · cited 1×
“…muscle cells (VSMCs) of the vasculature (Viswanathan & Saavedra, 1992; Leung et al., 1997; Nora et al., 1998; Allen et al., 1999;Wang et al., 1999; Wheeler-Schilling et al., 1999; Roulston et al., 2003), and importantly, expression is also increased in numerous cardiovascular pathologies (see…”
BackgroundParadoxical Role of Angiotensin II Type 2 Receptors in Resistance Arteries of Old Rats
Pinaud, F., Bocquet, A., Dumont, O., Retailleau, K., Baufreton, C., Andriantsitohaina, R., Loufrani, L., & Henrion, D. (2007) · Hypertension · doi:10.1161/hypertensionaha.106.085035 · Cited by 63 · cited 2×
“More recently, Pinaud et al.”
BackgroundHashimoto, N., Maeshima, Y., Satoh, M., Odawara, M., Sugiyama, H., Kashihara, N., Matsubara, H., Yamasaki, Y., & Makino, H. (2004) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00294.2003 · Cited by 62 · cited 4×
“…of overt renal damage, such as induced by renal ablation, subtotal nephrectomy, or kidney damage caused by protein overload, AT2R were invariably upregulated (Bautista et al., 2001; Cao et al., 2002; Ruiz-Ortega et al., 2003; Hashimoto et al., 2004; Tejera et al., 2004; Vazquez et al., 2005).”
BackgroundInfluentialExpression of angiotensin II AT2 receptor in the acute phase of stroke in rats
Zhu, Y. Z., Chimon, G. N., Zhu, Y.-C., Q Lu, B. L., Hu, H. Z., Yap, E., Lee, H. S., & Wong, P. T.-H. (2000) · Neuroreport · doi:10.1097/00001756-200004270-00009 · Cited by 62 · cited 4×
“Not surprisingly considering the contribution of AT 2 R to the effects of AT 1 R inhibition in other settings, attention has recently turned to the potential role of the AT 2 R in neuroprotection, particularly since AT 2 R is reported to be upregulated in stroke (Zhu et al., 2000; Li et al., 2005b; Lu et al., 2005) ,…”
BackgroundInfluentialLocalization of the Angiotensin II Receptor Subtypes in the Human Atrium
Brink, M. (1996) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1996.0168 · Cited by 61 · cited 3×
“Indeed, increased AT 2 R expression in the heart has been specifically localised to cardiac fibroblasts, suggesting a link between upregulation of AT 2 R expression and fibrosis present in hypertrophied and failing hearts (Brink et al., 1996; Tsutsumi et al., 1998; Wharton et al., 1998) .”
BackgroundHu, C., Dandapat, A., Chen, J., Liu, Y., Hermonat, P. L., Carey, R. M., & Mehta, J. L. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.11.006 · Cited by 61 · cited 1×
“Furthermore, using the same mouse model, Hu et al. (2008) have additionally provided evidence of AT2Rmediated regulation of collagen deposition in atherosclerotic plaques which involved reduced MMP expression, decreased macrophage deposition and increased superoxide dismutase.”
BackgroundRenal angiotensin II AT2receptors promote natriuresis in streptozotocin-induced diabetic rats
Hakam, A. C., Siddiqui, A. H., & Hussain, T. (2005) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00092.2005 · Cited by 61 · cited 4×
“On the other hand, AT2R expression has been found to be markedly increased in brush-border and basolateral membrane of the kidney (Hakam et al., 2006), and either not detected in the glomeruli of either diabetic or control rats (Hakam et al., 2006) or found to be significantly decreased (Wehbi et…”
BackgroundResultInfluentialFaure, S., Chapot, R., Tallet, D., Javellaud, J., Achard, J., & Oudart, N. (2006) · PubMed · Cited by 61
(1996) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(96)90295-3 · Cited by 61
Tissue-specific changes in angiotensin II receptors in streptozotocin-diabetic rats
Brown, L., Wall, D., Marchant, C., & Sernia, C. (1997) · Journal of Endocrinology · doi:10.1677/joe.0.1540355 · Cited by 60 · cited 2×
“Using the STZ-model of type 1 diabetes, both reductions (Kalinyak et al., 1993; Cheng et al., 1994; Brown et al., 1997; Bonnet et al., 2002) and increases (Brown et al., 1997; Wehbi et al., 2001) in AT1R have been reported.”
MethodImmunolocalization of ACE2 and AT 2 Receptors in Rabbit Atherosclerotic Plaques
Zulli, A., Burrell, L. M., Widdop, R. E., Black, M. J., Buxton, B. F., & Hare, D. L. (2005) · Journal of Histochemistry & Cytochemistry · doi:10.1369/jhc.5c6782.2005 · Cited by 60 · cited 2×
“Increased AT 2 R expression in atherosclerotic plaques in the same ApoE-deficient mouse model was recently confirmed (Johansson et al., 2005; Vinh et al., 2008b) , and increased AT 2 R and ACE2 immunoreactivity was found in atherosclerotic plaques in rabbits, often co-localised with macrophages (Zulli et al., 2006) .”
BackgroundSelf-citationOkumura, M., Iwai, M., Ide, A., Mogi, M., Ito, M., & Horiuchi, M. (2005) · HYPERTENSION · doi:10.1161/01.hyp.0000178564.14464.80 · Cited by 60 · cited 2×
“In addition, (Okumura et al., 2005) reported that the upregulation of vascular AT 2 R, but not AT 1 R, following cuff injury was greater in female mice, and was associated with a greater reduction in neointimal formation as well as in indices of inflammation and oxidative stress in females versus males.”
BackgroundPrevention of Cardiac Hypertrophy by Angiotensin II Type-2 Receptor Gene Transfer
Metcalfe, B. L., Huentelman, M. J., Parilak, L. D., Taylor, D. G., Katovich, M. J., Knot, H. J., Sumners, C., & Raizada, M. K. (2004) · Hypertension · doi:10.1161/01.hyp.0000127563.14064.fd · Cited by 60 · cited 26×
“However, in analogous experiments, Duke et al. (2005a) reported that AT2R contributed to the BP-lowering and mesenteric vasodilator effect of candesartan in normotensive, but not hypertensive (SHR, 2K1C) rats.”
BackgroundMethodInfluentialPresence of angiotensin II AT2 receptor binding sites in the adventitia of human kidney vasculature.
Zhuo, J. L., Dean, R. G., MacGregor, D. P., Alcorn, D., & Mendelsohn, F. A. O. (1996) · PubMed · Cited by 59
Renal Interstitial cGMP Mediates Natriuresis by Direct Tubule Mechanism
Jin, X., Siragy, H. M., & Carey, R. M. (2001) · Hypertension · doi:10.1161/01.hyp.38.3.309 · Cited by 59 · cited 1×
“Seminal studies by Siragy and Carey (1996, 1997, 1999) (Jin et al., 2001; Jin et al., 2004) demonstrated that increased renal interstitial levels of cGMP, NO and BK were dependent on AT2R activation, and led to natriuresis.”
BackgroundSugino, H., Ozono, R., Kurisu, S., Matsuura, H., Ishida, M., Oshima, T., Kambe, M., Teranishi, Y., Masaki, H., & Matsubara, H. (2001) · Hypertension · doi:10.1161/01.hyp.37.6.1394 · Cited by 58 · cited 2×
“Ang II infusion also resulted in a comparable increase in cardiac hypertrophy in mice with cardiac specific over-expression of AT 2 R, to that of wild type mice (Sugino et al., 2001; Kurisu et al., 2003) .”
BackgroundEffect of renin inhibition and AT1R blockade on myocardial remodeling in the transgenic Ren2 rat
Whaley‐Connell, A. T., Habibi, J., Cooper, S. A., DeMarco, V. G., Hayden, M. R., Stump, C. S., Link, D. C., Ferrario, C. M., & Sowers, J. R. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00752.2007 · Cited by 58 · cited 2×
“More recently, aliskiren has proven to be beneficial in several pathophysiological settings including hypertension and diabetic nephropathy (Feldman et al., 2008), cardiac remodelling and fibrosis (Pilz et al., 2005; Whaley-Connell et al., 2008) as well as atherosclerosis (Lu et al., 2008).”
BackgroundTejera, N., Gómez‐Garré, D., Lázaro, A., Gallego‐Delgado, J., Alonso, C., Blanco, J., Ortíz, A., & Egido, J. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63740-6 · Cited by 58 · cited 4×
“…of overt renal damage, such as induced by renal ablation, subtotal nephrectomy, or kidney damage caused by protein overload, AT2R were invariably upregulated (Bautista et al., 2001; Cao et al., 2002; Ruiz-Ortega et al., 2003; Hashimoto et al., 2004; Tejera et al., 2004; Vazquez et al., 2005).”
BackgroundInfluentialMatrougui, K., Levy, B. I., & Henrion, D. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703371 · Cited by 56 · cited 2×
“…there is little evidence of AT2R-mediated vasorelaxation in arteries taken from untreated hypertensive animals (Matrougui et al., 1999; Matrougui et al., 2000; Cosentino et al., 2005) which contrasts the afore- mentioned in vivo data (Barber et al., 1999; Li & Widdop, 2004; Walters et…”
BackgroundResultAngiotensin Receptor Blockers Do Not Increase Risk ofMyocardial Infarction
Tsuyuki, R. T., & McDonald, M. A. (2006) · Circulation · doi:10.1161/circulationaha.105.594978 · Cited by 56
Vascular Hypertrophy and Increased P70S6 Kinase in Mice Lacking the Angiotensin II AT2 Receptor
Brede, M., Hadamek, K., Meinel, L., Wiesmann, F., Peters, J., Engelhardt, S., Simm, A., Haase, A., Lohse, M., & Hein, L. (2001) · Circulation · doi:10.1161/hc4601.099401 · Cited by 55 · cited 1×
“Furthermore, both basal media:lumen ratio, and vascular hypertrophy due to pressure overload was significantly elevated in aortic, femoral (Brede et al., 2001), and coronary (Akishita et al., 2000b; Wu et al., 2002) vessels of AT2R knockout mice compared to wild type controls, indicating an…”
BackgroundSimon, G., Íllyés, G., & Csiky, B. (1998) · Hypertension · doi:10.1161/01.hyp.32.4.654 · Cited by 55 · cited 2×
“correlated with the occurrence of future cardiovascular disorders such as left ventricular hypertrophy (LVH), cardiac failure, arteriosclerosis, and stroke (Unger et al., 1996; Weber, 1997; Simon et al., 1998).”
BackgroundNO and cGMP mediate angiotensin AT2receptor-induced renal renin inhibition in young rats
Siragy, H. M., Inagami, T., & Carey, R. M. (2007) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00014.2007 · Cited by 54 · cited 1×
“Furthermore, renal AT2R have recently been shown to inhibit renin biosynthesis and subsequent local Ang II production, thus providing an additional mechanism for modulation of AT1Rmediated effects (Siragy et al., 2007).”
BackgroundHiyoshi, H., Yayama, K., Takano, M., & Okamoto, H. (2004) · Hypertension · doi:10.1161/01.hyp.0000128022.24598.4f · Cited by 54 · cited 3×
“Hypertension, 43, 1258 -63.”
BackgroundThe renin-angiotensin system in streptozotocin-induced diabetes mellitus in the rat.
Kalinyak, J. E., Sechi, L. A., Griffin, C. A., Don, B. R., Tavangar, K., Kraemer, F. B., Hoffman, A. R., & Schambelan, M. (1993) · Journal of the American Society of Nephrology · doi:10.1681/asn.v461337 · Cited by 54
Min, L.-J., Cui, T.-X., Yahata, Y., Yamasaki, K., Shiuchi, T., Liu, H.-W., Chen, R., Li, J.-M., Okumura, M., Jinno, T., et al. (2004) · Endocrinology · doi:10.1210/en.2003-0673 · Cited by 52 · cited 1×
“In contrast, Min et al. (2004) demonstrated a diminution of collagenase activity by AT2R blockade which was associated with increased tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) expression, and selective AT2R stimulation with CGP42112 increased matrix metalloproteinase-1 (MMP-1)…”
BackgroundConstrictor and Dilator Effects of Angiotensin II on Cerebral Arterioles
Vincent, J.-M., Kwan, Y. W., Chan, S., Perrin‐Sarrado, C., Atkinson, J., & Chillon, J. (2005) · Stroke · doi:10.1161/01.str.0000190002.79052.bf · Cited by 52 · cited 2×
“In accordance with many studies describing AT 2 R-mediated relaxation of peripheral arteries (see Section 3.1), Ang II caused AT 1 R-mediated vasoconstriction in cerebral arteries both in vitro and in vivo; an effect of Ang II that was converted to AT 2 R-mediated vasodilatation in the presence of an AT 1 R antagonist…”
BackgroundResultInfluentialHakam, A. C., & Hussain, T. (2006) · Hypertension · doi:10.1161/01.hyp.0000220112.91724.fc · Cited by 51 · cited 1×
“…effects of AT2R may involve altered proximal tubule bicarbonate reabsorption involving phosholipase A and arachidonic acid (Haithcock et al., 1999), or by direct inhibition by AT2R of the proximal tubule sodium pump via NO/ cGMP signalling as has recently been postulated (Hakam & Hussain, 2006a,b).”
MethodBonnet, F., Candido, R., Carey, R. M., Casley, D., Russo, L. M., Osicka, T. M., Cooper, M. E., & Cao, Z. (2002) · Journal of Hypertension · doi:10.1097/00004872-200208000-00025 · Cited by 50 · cited 4×
“Using the STZ-model of type 1 diabetes, both reductions (Kalinyak et al., 1993; Cheng et al., 1994; Brown et al., 1997; Bonnet et al., 2002) and increases (Brown et al., 1997; Wehbi et al., 2001) in AT1R have been reported.”
BackgroundMethodInfluentialFalcón, B. L., Stewart, J. M., Bourassa, E. A., Katovich, M. J., Walter, G. A., Speth, R. C., Sumners, C., & Raizada, M. K. (2004) · Physiological Genomics · doi:10.1152/physiolgenomics.00170.2004 · Cited by 50 · cited 2×
“In more recent studies in which AT 2 R were over-expressed via a lentiviral vector gene delivery system in cardiomyocytes of 5 day old SHR (Metcalfe et al., 2004) , or Sprague-Dawley rats (Falcon et al., 2004) , AT 2 R over-expression reduced cardiac hypertrophy at 21 weeks of age compared to control SHR, and attenuat…”
MethodTISSUE RENIN-ANGIOTENSIN SYSTEM:A Site of Drug Action?
and, B. G. Z., & Dunham, E. W. (1997) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.37.1.53 · Cited by 50 · cited 22×
“Vascular remodelling associated with hypertension occurs at all levels of the vascular tree, and increased local expression of RAS components and subsequent enhanced local Ang II production (Shiota et al., 1992; Jandeleit-Dahm et al., 1997; Wang et al., 2003), implies an important role of the RAS in this process.”
BackgroundInfluentialChangyun, L., Linsheng, C., Zeng, Q., Liu, X., Zhang, Y., Dai, T., Hu, D., Huang, K., Wang, Y., Wang, X., et al. (2005) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-005-0443-x · Cited by 49 · cited 5×
“…in other settings, attention has recently turned to the potential role of the AT2R in neuroprotection, particularly since AT2R is reported to be upregulated in stroke (Zhu et al., 2000; Li et al., 2005b; Lu et al., 2005), specifically in the ischemic area of the brain (Mogi et al., 2006).”
BackgroundInfluentialLorenzo, Ó., Ruiz‐Ortega, M., Suzuki, Y., Rupérez, M., Esteban, V., Sugaya, T., & Egido, J. (2002) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1351162 · Cited by 48
Campbell, D. J. (1996) · PubMed · Cited by 48
Duke, L. M., Evans, R. G., & Widdop, R. E. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01096.2004 · Cited by 48 · cited 2×
“Moreover, in 2K1C hypertensive rats, the AT2R antagonist increased basal medullary flow, suggestive of AT2R-mediated medullary vasoconstriction (Duke et al., 2005b).”
BackgroundSelf-citationBové, C. M., Yang, Z., Gilson, W. D., Epstein, F. H., French, B. A., Berr, S. S., Bishop, S. P., Matsubara, H., Carey, R. M., & Kramer, C. M. (2004) · Hypertension · doi:10.1161/01.hyp.0000115924.94236.91 · Cited by 47 · cited 2×
“AT2R-mediated cardioprotection has been shown to involve NO signalling, as NO synthase inhibition prevented the beneficial effects of AT2R over-expression on LV function (Bove et al., 2004).”
MethodModulation of AT1 receptor‐mediated contraction of rat uterine artery by AT2 receptors
Zwart, A. S., Davis, E. A., & Widdop, R. E. (1998) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702210 · Cited by 47 · cited 1×
“In terms of vascular AT 2 R, the vasoconstrictor response of human isolated coronary microarteries to Ang II was potentiated by PD123319, as seen in in vitro animal studies (Zwart et al., 1998; Hannan et al., 2003) , and the magnitude of this effect was positively correlated with the age of the donor (Batenburg et al.…”
BackgroundSelf-citationZhuo, J. L., Dean, R. G., MacGregor, D. P., Alcorn, D., & Mendelsohn, F. A. O. (1996) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1996.tb03077.x · Cited by 47 · cited 2×
“AT 2 R are detected in human kidneys, primarily in associated vasculature (Zhuo et al., 1996; Matsubara et al., 1998) , but also in tubular and glomerular tissue of patients with glomerular lesions (Mifune et al., 2001) .”
BackgroundBatlle, M., Roig, E. S., Pérez‐Villa, F., Lario, S., Cejudo–Martín, P., García‐Pras, E., Ortiz, J., Roqué, M., Orús, J., Rigol, M., et al. (2006) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2006.04.012 · Cited by 47 · cited 1×
“However, in direct contrast, Batlle et al. (2006) found no evidence of increased ACE2 activity in biopsies of human heart failure patients.”
BackgroundBarker, T., Massett, M. P., Korshunov, V. A., Mohan, A. M., Kennedy, A. J., & Berk, B. C. (2006) · Hypertension · doi:10.1161/01.hyp.0000241061.51003.b7 · Cited by 45 · cited 2×
“Interestingly, both RAS inhibitors caused anti-remodelling of balloon-injured rat carotid arteries, but by different molecular mechanisms since only valsartan caused increased AT2R expression together with increased cGMP production (Barker et al., 2006).”
BackgroundFirst Reported Nonpeptide AT1Receptor Agonist (L-162,313) Acts as an AT2Receptor Agonist in Vivo
Wan, Y., Wallinder, C., Johansson, B., Holm, M., Mahalingam, A. K., Wu, X., Botros, M., Karlén, A., Pettersson, A., Nyberg, F., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm031031i · Cited by 45 · cited 26×
“However, in analogous experiments, Duke et al. (2005a) reported that AT2R contributed to the BP-lowering and mesenteric vasodilator effect of candesartan in normotensive, but not hypertensive (SHR, 2K1C) rats.”
BackgroundInfluentialDandapat, A., Hu, C. P., Chen, J., Liu, Y., Khan, J. A., Remeo, F., Carey, R. M., Hermonat, P. L., & Mehta, J. L. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.11.061 · Cited by 45 · cited 1×
“Interestingly, Dandapat et al. (2008) have recently reported that over-expression of the AT2R in LDL-receptor knockout mice, abrogated atherosclerotic lesion development, and was associated with a reduction in oxidative stress and other factors involved in the pro-inflammatory cascade.”
BackgroundBeyond blood pressure: new roles for angiotensin II
Lucius, R., GALLINAT, S., Busche, S., Rosenstiel, P. C., & Unger, T. (1999) · Cellular and Molecular Life Sciences · doi:10.1007/s000180050490 · Cited by 45 · cited 2×
“Thus AT2R contribute to the cellular mechanisms allowing adaptation to ischemic insult, by stimulating both tissue repair and programmed cell death (Lucius et al., 1999).”
BackgroundA Place in Our Hearts for the Lowly Angiotensin 1-7 Peptide?
Reudelhuber, T. L. (2006) · Hypertension · doi:10.1161/01.hyp.0000209020.69734.73 · Cited by 44 · cited 1×
“Updated biochemical and functional aspects of Ang (1–7) have recently been reviewed (Ferrario et al., 2005b; Ferrario, 2006; Reudelhuber, 2006; Santos & Ferreira, 2007).”
BackgroundDiabetes and retinal vascular disorders: role of the renin–angiotensin system
Wilkinson‐Berka, J. L. (2004) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399404008129 · Cited by 43 · cited 1×
“There is evidence that Ang II and VEGF and their cognate receptors participate in retinal angiogenesis and ischaemic retinopathies such as diabetic retinopathy (see Wilkinson-Berka, 2004).”
BackgroundWarnecke, C., Mugrauer, P., Sürder, D., Erdmann, J., Schubert, C., & Regitz‐Zagrosek, V. (2005) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00385.2005 · Cited by 42 · cited 2×
“However, the interpretation of these findings is somewhat unclear as the same group has reported that the G allele represents either decreased AT2R function (Nishimura et al., 1999; Alfakih et al., 2004; Alfakih et al., 2005) or increased AT2R function (Warnecke et al., 2005; Strauss & Hall, 2006).”
BackgroundRosenström, U., Sköld, C., Plouffe, B., Beaudry, H., Lindeberg, G., Botros, M., Nyberg, F., Wolf, G., Karlén, A., Gallo‐Payet, N., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm0491492 · Cited by 42 · cited 1×
“In addition, a number of other peptide-based AT2R mimetics have been made by the same research group following extensive structure–activity relationships using Ang II or analogues (Johannesson et al., 2004; Georgsson et al., 2005; Rosenstrom et al., 2005; Georgsson et al., 2006).”
BackgroundPressure Mediates Angiotensin II–Induced Arterial Hypertrophy and PDGF-A Expression
Parker, S. B., Wade, S. S., & Prewitt, R. L. (1998) · Hypertension · doi:10.1161/01.hyp.32.3.452 · Cited by 42 · cited 1×
“Furthermore, other factors involved in cellular growth and ECM production which are known to be stimulated by Ang II, such as growth factors (Parker et al., 1998; Su et al., 2002), factors involved in the inflammatory response (Chou et al., 1998) and reactive oxygen species (ROS) (Virdis et al.,…”
BackgroundJin, X., McGrath, H. E., Gildea, J. J., Siragy, H. M., Felder, R. A., & Carey, R. M. (2004) · Hypertension · doi:10.1161/01.hyp.0000123574.60586.7d · Cited by 41 · cited 1×
“Seminal studies by Siragy and Carey (1996, 1997, 1999) (Jin et al., 2001; Jin et al., 2004) demonstrated that increased renal interstitial levels of cGMP, NO and BK were dependent on AT2R activation, and led to natriuresis.”
BackgroundCandesartan reduces superoxide production after global cerebral ischemia
Sugawara, T., Kinouchi, H., Oda, M., Shoji, H., Omae, T., & Mizoi, K. (2005) · Neuroreport · doi:10.1097/00001756-200503150-00004 · Cited by 41 · cited 3×
“In addition, Sugawara et al. (2005) recently demonstrated that a nonhypotensive dose of an AT1 receptor antagonist reduced superoxide production and improved neurological outcome following global ischemia (Sugawara et al., 2005).”
BackgroundInfluentialVASCULAR ANGIOTENSIN AT2RECEPTORS IN HYPERTENSION AND AGEING
Widdop, R. E., Vinh, A., Henrion, D., & Jones, E. S. (2008) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2008.04883.x · Cited by 40 · cited 4×
“For further detailed analysis of AT 2 R-mediated relaxation/vasodilatation, see (Hannan & Widdop, 2004; Henrion et al., 2001; Widdop et al., 2008) .”
BackgroundResultInfluentialSelf-citationRegulation of the angiotensin AT1 receptor expression by hypercholesterolemia.
Nickenig, G., & Böhm, M. (1997) · PubMed · Cited by 40
Campbell, D. J. (1996) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1996.tb03073.x · Cited by 40
Interaction between AT1 and AT2 receptors during postinfarction left ventricular remodeling
Vörös, S., Yang, Z., Bové, C. M., Gilson, W. D., Epstein, F. H., French, B. A., Berr, S. S., Bishop, S. P., Conaway, M. R., Matsubara, H., et al. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00886.2005 · Cited by 37 · cited 2×
“In addition, AT 2 R stimulation has been shown to be involved in the beneficial effects of sartans post-MI, as AT 1 R inhibition was found to be less effective during AT 2 R blockade (Liu et al., 1997) or AT 2 R-deletion (Xu et al., 2002) , and potentiated by AT 2 R-over-expression (Voros et al., 2006) .”
BackgroundAngiotensin II-dependent induction of AT2receptor expression after renal ablation
Vázquez, E., Coronel, I., Bautista, R., Romo, E., Villalón, C. M., Avila-Casado, M. C., Soto, V., & Escalante, B. (2004) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00216.2004 · Cited by 36 · cited 3×
“…of overt renal damage, such as induced by renal ablation, subtotal nephrectomy, or kidney damage caused by protein overload, AT2R were invariably upregulated (Bautista et al., 2001; Cao et al., 2002; Ruiz-Ortega et al., 2003; Hashimoto et al., 2004; Tejera et al., 2004; Vazquez et al., 2005).”
BackgroundVaragić, J., Sušić, D., & Frohlich, E. D. (2001) · Hypertension · doi:10.1161/01.hyp.37.6.1399 · Cited by 36 · cited 25×
“However, in analogous experiments, Duke et al. (2005a) reported that AT2R contributed to the BP-lowering and mesenteric vasodilator effect of candesartan in normotensive, but not hypertensive (SHR, 2K1C) rats.”
BackgroundResultInfluentialN- and C-terminal structure–activity study of angiotensin II on the angiotensin AT2 receptor
Bouley, R., Pérodin, J., Plante, H., Řihakova, L., Bernier, S. G., Maletı́nská, L., Guillemette, G., & Escher, E. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01549-5 · Cited by 35 · cited 6×
“This hexapeptide has a much lower binding affinity than Ang II for AT2R (Bouley et al., 1998; Hansen et al., 2000), unlike AT4R; nevertheless there are functional data indicating that Ang IV exerts vascular effects via AT2R (Loufrani et al., 1999; Faure et al., 2006).”
BackgroundInfluentialFranco, R. J. D. S., Goldflus, S., McQuitty, M., Oigman, W., & On behalf of the valsartan/HCTZ combination therapy in brazil study group (2003) · Blood Pressure · doi:10.1080/080380203100022399 · Cited by 35
The Angiotensin II Type 2 Receptor and Improved Adjacent Region Function Post-MI
Bové, C. M., Gilson, W. D., Scott, C. D., Epstein, F. H., Yang, Z., DiMaria, J. M., Berr, S. S., French, B. A., Bishop, S. P., & Kramer, C. M. (2005) · Journal of Cardiovascular Magnetic Resonance · doi:10.1081/jcmr-200053461 · Cited by 34 · cited 2×
“The vast majority of investigators have deduced AT2Rmediated improvement of LV function and remodelling frommultiple studies performed in mouse models of either AT2R-deletion (Brede et al., 2003; Oishi et al., 2003) or over-expression (Yang et al., 2002; Bove et al., 2005).”
BackgroundJohansson, M. E., Wickman, A., Fitzgerald, S. M., Gan, L., & Bergström, G. M. L. (2005) · Journal of Hypertension · doi:10.1097/01.hjh.0000174078.95745.77 · Cited by 34 · cited 4×
“However, Johansson et al. (2005) were unable to reproduce this potentiation of lesion formation in the same model but using female mice.”
BackgroundInfluentialAlfakih, K., Lawrance, R. A., Maqbool, A., Walters, K., Ball, S. G., Balmforth, A. J., & Hall, A. S. (2004) · European Heart Journal · doi:10.1093/eurheartj/ehi013 · Cited by 32 · cited 4×
“Premature coronary artery disease has also been associated with the G allele (Alfakih et al., 2005).”
BackgroundInfluentialGeorgsson, J., Sköld, C., Plouffe, B., Lindeberg, G., Botros, M., Larhed, M., Nyberg, F., Gallo‐Payet, N., Gogoll, A., Karlén, A., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050280z · Cited by 32 · cited 1×
“In addition, a number of other peptide-based AT2R mimetics have been made by the same research group following extensive structure–activity relationships using Ang II or analogues (Johannesson et al., 2004; Georgsson et al., 2005; Rosenstrom et al., 2005; Georgsson et al., 2006).”
BackgroundAT1 receptor inhibition blunts angiotensin II-stimulated nitric oxide release in renal arteries.
Thorup, C., Kornfeld, M., Goligorsky, M. S., & Moore, L. C. (1999) · PubMed · Cited by 31
Angiotensin II Receptor Antagonists: Potential in Elderly Patients with Cardiovascular Disease
Burrell, L. M., & Johnston, C. I. (1997) · Drugs & Aging · doi:10.2165/00002512-199710060-00003 · Cited by 31
Angiotensin receptors: Physiology and pharmacology
Guthrie, G. P. (1995) · Clinical Cardiology · doi:10.1002/clc.4960181507 · Cited by 30 · cited 1×
“The AT 2 R shares 34% sequence homology to the AT 1 R (Guthrie, 1995; Unger et al., 1996) , and is expressed abundantly in foetal tissue, but levels decline rapidly after birth.”
BackgroundPhoon, S., & Howes, L. G. (2002) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.3317/jraas.2002.006 · Cited by 30 · cited 2×
“…an AT1R antagonist, uncovered acute haemodynamic effects due to AT2R, deduced from short-term infusions of PD123319, thus supporting a role for AT2R during AT1R blockade, albeit with some variation that likely reflects the different patient populations (Phoon & Howes, 2002; Gilles et al., 2004).”
BackgroundResultSexual dimorphism in the response of thoracic aorta from SHRs to losartan
Silva-Antonialli, M. M., Fortes, Z. B., de Carvalho, M. H. C., Scivoletto, R., & Nigro, D. (2000) · General Pharmacology The Vascular System · doi:10.1016/s0306-3623(00)00078-1 · Cited by 29 · cited 1×
“Indeed, losartan reduced BP more effectively within 24 h in female SHR than male SHR (Silva-Antonialli et al., 2000) .”
BackgroundJankowski, V., Vanholder, R. C., van der Giet, M., Henning, L., Tölle, M., Schönfelder, G., Krakow, A. M., Karadogan, S., Gustavsson, N., Gobom, J., et al. (2005) · Hypertension · doi:10.1161/01.hyp.0000177436.09733.d4 · Cited by 29 · cited 1×
“New mas spectroscopy techniques (Jankowski et al., 2005) for detection and quantification of plasma and tissue Ang peptides simultaneously should help address this issue.”
BackgroundJohannesson, P., Erdélyi, M., Lindeberg, G., Frändberg, P., Nyberg, F., Karlén, A., & Hallberg, A. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm049651m · Cited by 28 · cited 2×
“In addition, a number of other peptide-based AT 2 R mimetics have been made by the same research group following extensive structure-activity relationships using Ang II or analogues (Johannesson et al., 2004; Georgsson et al., 2005; Rosenstrom et al., 2005; Georgsson et al., 2006) .”
BackgroundCentral Pressor Actions of Aminopeptidase-Resistant Angiotensin II Analogs
Kokje, R. J., Wilson, W. L., Brown, T. E., et al. (2007) · Hypertension · doi:10.1161/hypertensionaha.107.087130 · Cited by 28 · cited 2×
“However, this view has recently been challenged (Kokje et al., 2007).”
BackgroundCharacterization of a rat type 2 angiotensin II receptor stably expressed in 293 cells
Mukoyama, M., Horiuchi, M., Nakajima, M., Pratt, R. E., & Dzau, V. J. (1995) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(95)03586-v · Cited by 28 · cited 5×
“The reproducible nature of AT2R function is consistent with a lack of AT2R internalization previously reported (Mukoyama et al., 1995; Hein et al., 1997) and hence lack of desensitization.”
BackgroundInfluentialGrammatopoulos, T. N., Morris, K. S., FERGUSON, P. W., & Weyhenmeyer, J. A. (2002) · Molecular Brain Research · doi:10.1016/s0169-328x(02)00101-8 · Cited by 28 · cited 2×
“AT 2 R-mediated apoptosis (Zhu et al., 2000; Grammatopoulos et al., 2002) is one possibility.”
BackgroundCardiac hypertrophy and fibrosis in chronic l-NAME-treated AT2 receptor-deficient mice
Groß, V., Obst, M., Kiss, É., Janke, J., Mazák, I., Shagdarsuren, E., Müller, D. N., Langenickel, T., Gröne, H., & Luft, F. C. (2004) · Journal of Hypertension · doi:10.1097/00004872-200405000-00023 · Cited by 27 · cited 1×
“…promotion of interstitial fibrosis by either aortic banding or L-NAMEwas augmented in AT2R knockout mice (Akishita et al., 2000b; Wu et al., 2002; Gross et al., 2004) and cardiac specific over-expression of AT2R diminished the amount of both perivascular and interstitial fibrosis induced by Ang…”
BackgroundCardiac Senescence Is Associated with Enhanced Expression of Angiotensin II Receptor Subtypes
Heymes, C. (1998) · Endocrinology · doi:10.1210/en.139.5.2579 · Cited by 26
Synthesis and AT2 receptor‐binding properties of angiotensin II analogues
Rosenström, U., Sköld, C., Lindeberg, G., Botros, M., Nyberg, F., Hallberg, A., & Karlén, A. (2004) · Journal of Peptide Research · doi:10.1111/j.1399-3011.2004.00184.x · Cited by 26 · cited 2×
“On the other hand, there are substantial binding data suggesting that Ang III has 5–10 times higher affinity for AT2R over AT1R (Dudley et al., 1990; Timmermans et al., 1991; Rosenstrom et al., 2004), and indeed possesses higher affinity than Ang II itself at AT2R (Mukoyama et al.”
BackgroundAngiotensin IV-evoked vasoprotection is conserved in advanced atheroma
Vinh, A., Widdop, R. E., Chai, S. Y., & Gaspari, T. A. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.12.042 · Cited by 26 · cited 6×
“Increased AT 2 R expression in atherosclerotic plaques in the same ApoE-deficient mouse model was recently confirmed (Johansson et al., 2005; Vinh et al., 2008b) , and increased AT 2 R and ACE2 immunoreactivity was found in atherosclerotic plaques in rabbits, often co-localised with macrophages (Zulli et al., 2006) .”
BackgroundResultInfluentialSelf-citationWarnecke, C., Kaup, D., Marienfeld, U., Poller, W. C., Yankah, C., Gräfe, M., Fleck, E., & Regitz‐Zagrosek, V. (2001) · Journal of Molecular Medicine · doi:10.1007/s001090100243 · Cited by 24 · cited 2×
“In contrast, several other investigators have reported a lack of effect of AT 2 R on collagen secretion, since Ang II stimulation of collagen production in cultured rat and porcine cardiac fibroblasts, and rat mesenteric VSMCs was inhibited by AT 1 R blockade, but unaffected by AT 2 R inhibition (Lijnen et al., 2000;…”
BackgroundGeorgsson, J., Sköld, C., Botros, M., Lindeberg, G., Nyberg, F., Karlén, A., Hallberg, A., & Larhed, M. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm0613469 · Cited by 23 · cited 2×
“new peptide-based ligands have been designed that may become lead compounds for future drug development (Georgsson et al., 2007).”
BackgroundAngiotensin II and nitric oxide in neural control of intrarenal blood flow
Rajapakse, N. W., Sampson, A. K., Eppel, G. A., et al. (2005) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00477.2004 · Cited by 22 · cited 2×
“Likewise, endogenous Ang II acting via both AT1R and AT2R would appear to enhance renal neurovascular function in rabbit kidneys (Rajapakse et al., 2005, 2006).”
BackgroundDanser, A. J., & Deinum, J. (2005) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.3317/jraas.2005.025 · Cited by 22
Short pseudopeptides containing turn scaffolds with high AT2 receptor affinity
Georgsson, J., Rosenström, U., Wallinder, C., Beaudry, H., Plouffe, B., Lindeberg, G., Botros, M., Nyberg, F., Karlén, A., Gallo‐Payet, N., et al. (2006) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2006.05.019 · Cited by 18 · cited 2×
“In addition, a number of other peptide-based AT 2 R mimetics have been made by the same research group following extensive structure-activity relationships using Ang II or analogues (Johannesson et al., 2004; Georgsson et al., 2005; Rosenstrom et al., 2005; Georgsson et al., 2006) .”
BackgroundBrillante, D., O’Sullivan, A., Johnstone, M. T., & Howes, L. G. (2007) · Clinical Science · doi:10.1042/cs20070132 · Cited by 17 · cited 1×
“Furthermore, in line with earlier in vivo vascular AT2R function (see Section 3.1), Howes' group has recently examined small-artery vascular stiffness and in fact found that there was increased functional expression of vascular AT2R in patients with insulin resistance (Brillante et al., 2008).”
BackgroundInfluentialIsbell, D. C., Vörös, S., Yang, Z., DiMaria, J. M., Berr, S. S., French, B. A., Epstein, F. H., Bishop, S. P., Wang, H., Roy, R. J., et al. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00997.2007 · Cited by 16 · cited 2×
“BK has also been implicated in cardiac AT2R-mediated effects, as pharmacological inhibition of B2R in rats (Liu et al., 1997), or B2R deletion in mice (Isbell et al., 2007), was shown to prevent the anti-fibrotic influence of AT2R stimulation.”
BackgroundRoulston, C. L., Lawrence, A. J., Jarrott, B., et al. (2003) · Brain Research · doi:10.1016/s0006-8993(03)02231-5 · Cited by 16 · cited 1×
“…of the vasculature (Viswanathan & Saavedra, 1992; Leung et al., 1997; Nora et al., 1998; Allen et al., 1999;Wang et al., 1999; Wheeler-Schilling et al., 1999; Roulston et al., 2003), and importantly, expression is also increased in numerous cardiovascular pathologies (see Section 3 and Table 2).”
BackgroundVascular angiotensin II actions mediated by angiotensin II type 2 receptors
Hannan, R. E., & Widdop, R. E. (2004) · Current Hypertension Reports · doi:10.1007/s11906-004-0086-5 · Cited by 15 · cited 4×
“For further detailed analysis of AT 2 R-mediated relaxation/vasodilatation, see (Hannan & Widdop, 2004; Henrion et al., 2001; Widdop et al., 2008) .”
BackgroundInfluentialSelf-citationANG II type 2 receptors and neural control of intrarenal blood flow
Rajapakse, N. W., Eppel, G. A., Widdop, R. E., & Evans, R. G. (2006) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00183.2006 · Cited by 12 · cited 2×
“Likewise, endogenous Ang II acting via both AT1R and AT2R would appear to enhance renal neurovascular function in rabbit kidneys (Rajapakse et al., 2005, 2006).”
BackgroundSelf-citationBrillante, D., Johnstone, M. T., & Howes, L. G. (2005) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.3317/jraas.2005.007 · Cited by 12 · cited 2×
“In healthy male volunteers, intravascular administration of PD123319 had no effect on systemic vascular resistance or arterial stiffness, providing no evidence for acute AT 2 R-mediated haemodynamic effects (Phoon & Howes, 2001; Brillante et al., 2005) .”
Background
Cited by
Natural products as sources of new drugs over the 30 years from 1981 to 2010
Newman, D. J., & Cragg, G. M. (2012) · Journal of Natural Products · doi:10.1021/np200906s · Cited by 4,687
Bernardo, B. C., Weeks, K. L., Pretorius, L., & McMullen, J. R. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.04.005 · Cited by 894
ACE2: The Major Cell Entry Receptor for SARS-CoV-2
Scialo, F., Daniele, A., Amato, F., Pastore, L., Matera, M. G., Cazzola, M., Castaldo, G., & Bianco, A. (2020) · Lung · doi:10.1007/s00408-020-00408-4 · Cited by 481
Iwai, M., & Horiuchi, M. (2009) · Hypertension Research · doi:10.1038/hr.2009.74 · Cited by 296
Relative affinity of angiotensin peptides and novel ligands at AT1 and AT2 receptors
Bosnyak, S., Jones, E. S., Christopoulos, A., Aguilar, M.-I., Thomas, W. G., & Widdop, R. E. (2011) · Clinical Science · doi:10.1042/cs20110036 · Cited by 288
Self-citation
Metadata
- Authors
- Jones, E. S., Vinh, A., McCarthy, C. A., Gaspari, T. A., & Widdop, R. E.
- Venue
- Pharmacology & Therapeutics
- Publisher
- Elsevier BV
- Published
- 2008-12
- Volume
- 120
- Issue
- 3
- Pages
- 292-316
- ISSN
- 0163-7258 (ISSN-L)
- OpenAlex
- W1979582673
- Cited by
- 237
- References
- 401
- FWCI
- 9.68
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.